Cleveland Clinic's Ali Mehdi, MD, MEd, on the limits of current IgA nephropathy risk tools and where phenotyping could take treatment next.
Ali Mehdi, MD, MEd
Advertisement
Ali Mehdi, MD, MEd, is a board-certified nephrologist at Cleveland Clinic, where he also serves as assistant professor of medicine at the Lerner College of Medicine at Case Western Reserve University.
Articles by Ali Mehdi, MD, MEd
Rethinking IgA Nephropathy Risk and Treatment, With Ali Mehdi, MD, MEd
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on HCPLive
1
Tilrekimig Meets EASI-75 Goal in Atopic Dermatitis, With Eric Simpson, MD
2
Tips on Optimizing HS Biologics, Combinations, and Surgery
3
FDA Approves Once-Monthly Subcutaneous Olanzapine for Schizophrenia
4
FAQ: ASH's New Ferritin Thresholds, With Jacquelyn Powers, MD, MS
5